News

GODDYN wins 2015 Global Law Experts Award

GODDYN has great pleasure in announcing that Bart GODDYN, who is the firm’s managing partner, has been chosen as the 2015 winner in the category ‘Transactions Lawyer of the Year in Belgium’ by Global Law Experts (GLE).   The award rewards excellence of GODDYN’s transactional and advisory work in the area of Intellectual Property and R&D.   Over recent months, GLE has conducted its extensive nomination and research process for…

Read More

Release of book on copyright for media professionals

GODDYN has great pleasure in announcing the publication of a book on copyright for media professionals by Wim CRIEL (Roularta Media Group). The book, to which Bart GODDYN has contributed, was released on a press conference today. “It has been an honour, a privilege and a pleasure to have contributed to the writing of Wim’s book. The publication is the result of Wim’s remarkable perseverance to have the complex matter…

Read More

GODDYN advises TiGenix on agreement with Lonza

GODDYN has advised TiGenix (Euronext Brussels: TIG) on an agreement with Lonza for the manufacture of stem cell-based treatment of complex perianal fistulas in Crohn’s disease. TiGenix is an advanced biopharmaceutical company focused on developing and commercialising novel therapeutics from allogeneic expanded adipose-derived stem cells (eASCs) in inflammatory and autoimmune diseases. Lonza is a global leader in biological and cell therapy manufacturing. TiGenix and Lonza announced today an agreement for…

Read More

GODDYN strengthens its legal work for TiGenix

GODDYN further strengthens its legal work for TiGenix (external link). TiGenix NV (NYSE Euronext: TIG) is a leading European cell therapy company with a commercial product and a strong clinical stage pipeline of adult stem cell programmes. Bart GODDYN (through GODDYN BVBA) will continue to cover a broad range of legal matters relevant to the bio-tech industry with a special focus on transactional and advisory work for TiGenix’s R&D, clinical,…

Read More

Bart GODDYN wins 2014 Corporate Intl Legal Award

GODDYN has great pleasure in announcing that Bart GODDYN, who is the firm’s managing partner, was selected as the 2014 winner of the ‘Transactions Lawyer of the Year in Belgium’ by Corporate Intl Magazine. The award rewards excellence of GODDYN’s transactional and advisory work in the area of Intellectual Property and R&D. The Corporate Intl Legal Awards recognize firms in their chosen specialism and reward excellence not only in expertise…

Read More

Publication on the AstraZeneca case

Bart GODDYN published an article, entitled “The AstraZeneca Competition Case: Patent Strategies Constituting Abuse of Dominance”, in the summer edition of the International In-house Counsel Journal (Vol. 7, No. 28, Summer 2014, 1). In its landmark judgment of 6 December 2012, the Court of Justice of the European Union affirmed that AstraZeneca had abused its dominant position by engaging in certain intellectual property strategies aimed at protecting its product against…

Read More

Seminar on R&D contracts

On 16 October 2014, Bart GODDYN spoke about industry perspectives of research & development contracts at the seminar of the European Academy for Taxes, Economics & Law in Berlin, Germany. Bart was invited for the eighth time as a speaker for this biannual conference. Topics included trade secrets, confidentiality, material transfer, intellectual property ownership and licensing.